ImageneBio, Inc. Public Float
ImageneBio, Inc. (IMA) had Public Float of $41.70 million as of 2025-06-30, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-10
- 2025-06-30: Entity Public Float $41.70M.
- 2024-06-28: Entity Public Float $51.30M.
- 2023-06-30: Entity Public Float $178.50M.
- 2022-12-31: Entity Public Float $58.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $41.70M 10-K · filed 2026-03-10 |
| 2024-06-28 | $51.30M 10-K · filed 2025-03-06 |
| 2023-06-30 | $178.50M 10-K · filed 2024-03-12 |
| 2022-12-31 | $58.00M 10-K · filed 2023-03-14 |
| 2021-06-30 | $296.70M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |